Fujifilm Restarting Avigan Trial in Japan to Treat COVID-19

• 3 years ago

Fujifilm suffered a setback with Avigan in December after the trial data was considered to be inconclusive since it wasn’t a double-blind study. Fujifilm’s new study will involve about 270 patients with the goal of seeking approval again in October for the treatment of mildly sick patients that are not pregnant.

Fujifilm is expected to test Avigan on patients with mild symptoms that are 65 or older along with mildly ill patients 50 or older with preexisting conditions like kidney disease and diabetes. Currently, Avigan is approved for the treatment of COVID-19 in  India and Indonesia.

Other Avigan/COVID-19/Hydro Ag +/Fujifilm Biomedical Coverage (1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37)

Please don’t forget to follow us on Facebook, Twitter, Instagram, YouTube

Plus our owners’ groups

Fujifilm GFX Owners Group

Fujifilm X-H Owners Group

Fujifilm X-T Owners Group

Fujifilm X-S Owners Group

Fujifilm X-Pro Owners Group

Fujifilm X-E Owners Group

Fujifilm X-A Owners Group

Fujifilm X100 Owners Group

via nikkei